This Edition
ARTICLE | Distillery Therapeutics
Targeting PGM3 to inhibit glycosylation for Alzheimer’s disease
BC Staff
June 26, 2026 2:44 PM UTC
BCIQ Company Profiles
University of Florida
BCIQ Company Profiles
University of Florida